Atlas Trials

Imaging Study to Compare Effects of Darolutamide and Enzalutamide With Respect to Placebo on the Blood Flow in the Brain in Healthy Male Volunteers.

Clinical trial NCT03704519 · COMPLETED

Trial details

NCT number
NCT03704519
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cerebrovascular Circulation
Start date
2018-10-23
Primary completion
2019-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.